Skip to main content
Premium Trial:

Request an Annual Quote

Anthony Caruso, Thomas Klaue

Premium
Anthony Caruso has joined Febit as vice president of informatics and application software, the firm said last week. Caruso’s responsibilities include the guidance of the company’s application development and supporting Febit's US customer base.
 
Prior to joining Febit, Caruso was president and founder of Source Code Genetics, an informatics consulting company focusing on decision support, data mining, and data management. In the past he also held similar positions at Lion Bioscience, Altana Pharma, and Genome Therapeutics.
 

 
Thomas Klaue has been named chief financial officer at MediGene, the firm said last week. He will assume his duties effective June 15.
 
Klaue is currently a partner at Fozzati Partners, a private investment bank in Frankfurt, Germany. He previously served as vice president of business development at Infineon Technologies where he helped establish its biochip business.
 
Klaue holds degrees in management education from the Massachusetts Institute of Technology and Harvard Business School.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.